Clinical trial
Safety and Efficacy of I-020502 in Meshed Skin Autografting
NCT00471939 · Kuros Biosurgery AG, Industry · Completed
Key facts
| NCT number | NCT00471939 |
|---|---|
| Title | Safety and Efficacy of I-020502 in Meshed Skin Autografting |
| Official title | A Phase II, Multi-Centre, Controlled Study of the Safety and Efficacy of Wound Healing Gel I-020502 (KUR-212) in Patients Undergoing Autologous Meshed Skin Grafting. |
| Lead sponsor | Kuros Biosurgery AG, Industry |
| Collaborators | Baxter BioScience Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Burns |
| Intervention type | Drug |
| Interventions | I-020502 |
| Enrollment | 10 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Jan 1, 2009 |
| First posted | May 10, 2007 |
| Last update posted | Mar 3, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: